What happens to a pharmaceutical product after it is approved? Is it meeting the clinical and safety expectations, and is it being used in the optimal patient populations in the most effective way? Real-world evidence (RWE) research is a fast-growing methodology used to provide essential information to health insurers, prescribers, patients, and manufacturers on a drug's use, efficacy, and safety – after it's approved and in use by the general patient population. RWE research is both costly and challenging to conduct, but the results, when derived from well-designed studies, can be extremely informative and improve patient health.
In a just-released podcast as part of HealthEconomics.Com's CONNECTED COMMUNITY series, Dr.
The podcast and blog focus on real-world evidence research in insomnia and chronic kidney disease, and feature a special section on challenges of conducting RWE in large private payers and new provider networks, such as Accountable Care Organizations (ACOs) and Integrated Delivery Networks (IDNs). Dr.
EPI-Q ( https://www.epi-q.com) is an international consulting firm providing high-quality research demonstrating clinical and economic benefits of medical therapies and technologies, thereby enhancing the quality of clinical practice and patient care. EPI-Q drives the development of evidence and value propositions to support product commercialization, facilitate market access, and optimize pricing and reimbursement. EPI-Q is a global organization with headquarters in
A pioneer in the field, HealthEconomics.Com (http://www.healtheconomics.com) is the top-ranked global link to pharmaceutical market access, health economics, and outcomes research. Offering a CONNECTED COMMUNITY for professionals involved in health economics, outcomes research, market access, health policy, reimbursement, and pricing, HealthEconomics.Com provides professionals with multiple ways to connect to news, policy updates, resources, events, and jobs via a popular website, newsletter service, virtual conference arena, blog, extensive social media platforms, and a webinar and podcast service. News Media interested in receiving the most current information on healthcare value and market access may access for free any resources and news on HealthEconomics.Com by visiting the website or by subscribing to multiple HealthEconomics.ComNewsletters.
Read the full story at http://www.prweb.com/releases/EpiQ_Podcast_Real_World/HealthEconomicsCom/prweb11897558.htm
Most Popular Stories
- Pandora Tumbles in Late Trading
- Stop-Start Engines Save Gas, Reduce Emissions
- Sporty Ford Fiesta Fires on All 3 Cylinders
- World Tensions Don't Curb Enthusiasm for Stocks
- Ohio State Band Chief Fired After Probe
- Shia LaBeouf Plea Deal, Alcoholism Treatment
- Visa, Amazon Results Drag Down the Street
- U.K. Economy Surpasses Pre-Crisis Peak
- Russia Fears Lasting Damage From Ukraine Crisis
- Hispanic Leader Goes the Extra Mile